Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Cerbios opens Swiss R&D center

by Rick Mullin
February 29, 2016 | A version of this story appeared in Volume 94, Issue 9

[+]Enlarge
Credit: Cerbios
Executives check out Cerbios’s new facilities.
A photo of executives checking out Cerbios’ new facilities.
Credit: Cerbios
Executives check out Cerbios’s new facilities.

The pharmaceutical services firm Cerbios-Pharma has opened an R&D center at its headquarters in Lugano, Switzerland, for the development of highly potent active pharmaceutical ingredients and monoclonal antibodies. The four-story, 1,120-m2 facility will house separate laboratories dedicated to biologics and small-molecule APIs manufactured to FDA’s current Good Manufacturing Practice quality standard.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.